Literature DB >> 15367417

Communication about the ending of anticancer treatment and transition to palliative care.

T Morita1, T Akechi, M Ikenaga, Y Kizawa, H Kohara, T Mukaiyama, T Nakaho, N Nakashima, Y Shima, T Matsubara, M Fujimori, Y Uchitomi.   

Abstract

BACKGROUND: Communication about the ending of anticancer treatment and transition to palliative care is a difficult task for oncologists. The primary aims of this study were to clarify family-reported degree of emotional distress and the necessity for improvement in communication methods when communicating about the ending of anticancer treatment, and to identify factors contributing to the levels of emotional distress and the necessity for improvement.
METHODS: A multi-center questionnaire survey was conducted on 630 bereaved family members of cancer patents who received specialized palliative care in Japan. A total of 318 responses were analyzed (effective response rate, 62%).
RESULTS: Thirty-nine percent of the bereaved family members reported that they were 'very distressed' in receiving information about the ending of anticancer treatment, and 19% reported 'considerable' or 'much' improvement was necessary in the communication methods. High-level emotional distress was significantly associated with younger patient age, female family gender, the experience of the physician stating she/he could do nothing for the patient, the physician's unwillingness to explore their feelings, and prognostic disclosure of definite survival periods without probabilities or ranges. High levels of perceived necessity for improvement in the communication methods were significantly associated with the experience of the physician stating she/he could do nothing for the patient, physicians not explaining treatment goals in specific terms, physicians not pacing the explanation with the state of family preparation, physicians not being knowledgeable about the most advanced treatments, and the atmosphere not being relaxing enough to ask questions.
CONCLUSIONS: In receiving the information about ending anticancer treatment, a considerable number of families experienced high levels of emotional distress and felt a need for improvement of the communication methods. The strategies to alleviate family distress could include: (i) assuring that physicians will do their best to achieve specific goals, without saying that they can do nothing for the patient; (ii) providing information, including estimated prognosis, in careful consideration of families' preparation and the uncertainty for each patient; (iii) exploring families' emotions and providing emotional support; (iv) acquiring knowledge about advanced treatments; and (v) making the atmosphere relaxing enough to allow families to ask questions.

Entities:  

Mesh:

Year:  2004        PMID: 15367417     DOI: 10.1093/annonc/mdh386

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  31 in total

1.  Effectiveness of using clinical guidelines for conducting palliative care family meetings in Japan.

Authors:  Mieko Fukui; Satoru Iwase; Naoko Sakata; Yujiro Kuroda; Kazuhiro Yoshiuchi; Keiichi Nakagawa; Karen Quinn; Peter L Hudson
Journal:  Support Care Cancer       Date:  2012-05-25       Impact factor: 3.603

2.  Gender, age and surgery as a treatment modality leads to higher distress in patients with cancer.

Authors:  Bejoy C Thomas; V NandaMohan; Madhvan K Nair; Manoj Pandey
Journal:  Support Care Cancer       Date:  2010-02-23       Impact factor: 3.603

3.  Palliative Care, Hospice, and Advance Care Planning: Views of People Living with HIV and Other Chronic Conditions.

Authors:  Jacquelyn Slomka; Maryjo Prince-Paul; Allison Webel; Barbara J Daly
Journal:  J Assoc Nurses AIDS Care       Date:  2016-02-12       Impact factor: 1.354

Review 4.  Current state of the art and science of patient-clinician communication in progressive disease: patients' need to know and need to feel known.

Authors:  Liesbeth M van Vliet; Andrew S Epstein
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

5.  "Rather one more chemo than one less…": Oncologists and Oncology Nurses' Reasons for Aggressive Treatment of Young Adults with Advanced Cancer.

Authors:  Katsiaryna Laryionava; Pia Heußner; Wolfgang Hiddemann; Eva C Winkler
Journal:  Oncologist       Date:  2017-11-13

6.  Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma.

Authors:  Yoshiyuki Yamagishi; Hajime Higuchi; Motoko Izumiya; Gen Sakai; Hideko Iizuka; Shoko Nakamura; Masayuki Adachi; Sigenari Hozawa; Hiromasa Takaishi; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2010-06-15       Impact factor: 7.527

7.  Living with advanced illness: longitudinal study of patient, family, and caregiver needs.

Authors:  Karen Tallman; Ruth Greenwald; Alice Reidenouer; Laurel Pantel
Journal:  Perm J       Date:  2012

8.  The importance of good death components among cancer patients, the general population, oncologists, and oncology nurses in Japan: patients prefer "fighting against cancer".

Authors:  Mitsunori Miyashita; Sachiko Kawakami; Daiki Kato; Hideomi Yamashita; Hiroshi Igaki; Kimiko Nakano; Yujiro Kuroda; Keiichi Nakagawa
Journal:  Support Care Cancer       Date:  2014-07-05       Impact factor: 3.603

Review 9.  Communication about cancer near the end of life.

Authors:  Anthony L Back; Wendy G Anderson; Lynn Bunch; Lisa A Marr; James A Wallace; Holly B Yang; Robert M Arnold
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

10.  Use of and reactions to a tailored CD-ROM designed to enhance oncologist-patient communication: the SCOPE trial intervention.

Authors:  Celette Sugg Skinner; Kathryn I Pollak; David Farrell; Maren K Olsen; Amy S Jeffreys; James A Tulsky
Journal:  Patient Educ Couns       Date:  2009-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.